Advanced search
Publication Cover
Emerging Microbes & Infections Volume 11, 2022 - Issue 1
Submit an article Journal homepage
2,160
Views
6
CrossRef citations to date
0
Altmetric
Coronaviruses

Shared IGHV1-69-encoded neutralizing antibodies contribute to the emergence of L452R substitution in SARS-CoV-2 variants

Qihong Yana State Key Laboratory of Respiratory Disease, Guangdong Laboratory of Computational Biomedicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, People’s Republic of China;b State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaView further author information
,
Ruitian Houa State Key Laboratory of Respiratory Disease, Guangdong Laboratory of Computational Biomedicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, People’s Republic of China;c Savaid Medical School, University of Chinese Academy of Science, Beijing, People’s Republic of ChinaView further author information
,
Xiaohan Huanga State Key Laboratory of Respiratory Disease, Guangdong Laboratory of Computational Biomedicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, People’s Republic of China;c Savaid Medical School, University of Chinese Academy of Science, Beijing, People’s Republic of ChinaView further author information
,
Yanjun Zhangb State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaView further author information
,
Ping Hea State Key Laboratory of Respiratory Disease, Guangdong Laboratory of Computational Biomedicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, People’s Republic of China;c Savaid Medical School, University of Chinese Academy of Science, Beijing, People’s Republic of ChinaView further author information
,
Yudi Zhanga State Key Laboratory of Respiratory Disease, Guangdong Laboratory of Computational Biomedicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, People’s Republic of China;c Savaid Medical School, University of Chinese Academy of Science, Beijing, People’s Republic of ChinaView further author information
,
Banghui Liua State Key Laboratory of Respiratory Disease, Guangdong Laboratory of Computational Biomedicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, People’s Republic of ChinaView further author information
,
Qian Wangb State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaView further author information
,
Haiyue Raob State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaView further author information
,
Xianying Chenb State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaView further author information
,
Xinwei Zhaoa State Key Laboratory of Respiratory Disease, Guangdong Laboratory of Computational Biomedicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, People’s Republic of ChinaView further author information
,
Xuefeng Niub State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaView further author information
,
Jincun Zhaob State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Xiaoli Xionga State Key Laboratory of Respiratory Disease, Guangdong Laboratory of Computational Biomedicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Ling Chena State Key Laboratory of Respiratory Disease, Guangdong Laboratory of Computational Biomedicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, People’s Republic of China;b State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 2749-2761 | Received 15 Aug 2022, Accepted 21 Oct 2022, Published online: 11 Nov 2022

References

  • Plante JA, Mitchell BM, Plante KS, et al. The variant gambit: COVID-19's next move. Cell Host Microbe. 2021;29(4):508–515. doi:10.1016/j.chom.2021.02.020. PubMed PMID: 33789086; PubMed Central PMCID: PMCPMC7919536.
  • McCallum M, Walls AC, Sprouse KR, et al. Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants. Science. 2021;374:1621–1626. doi:10.1126/science.abl8506. PubMed Central PMCID: PMC34751595.
  • Motozono C, Toyoda M, Zahradnik J, et al. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity. Cell Host Microbe. 2021;29(7):1124–1136. doi:10.1016/j.chom.2021.06.006. PubMed PMID: 34171266; PubMed Central PMCID: PMCPMC8205251.
  • Tchesnokova V, Kulasekara H, Larson L, et al. Acquisition of the L452R mutation in the ACE2-binding interface of spike protein triggers recent massive expansion of SARS-CoV-2 variants. J Clin Microbiol. 2021;59(11):e0092121. doi:10.1128/JCM.00921-21. PubMed PMID: 34379531; PMCID: PMC8525575.
  • Deng X, Garcia-Knight MA, Khalid MM, et al. Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant. Cell. 2021;184(13):3426–3437. doi:10.1016/j.cell.2021.04.025. PubMed PMID: 33991487; PubMed Central PMCID: PMCPMC8057738.
  • McCallum M, Bassi J, Marco AD, et al. SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern. Science. 2021;373:648–654.
  • Cao Y, Yisimayi A, Jian F, et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature. doi:10.1038/s41586-022-04980-y.
  • Petrova VN, Russell CA. The evolution of seasonal influenza viruses. Nat Rev Microbiol. 2018;16(1):47–60. doi:10.1038/nrmicro.2017.118. PubMed PMID: 29081496.
  • Windsor IW, Tong P, Lavidor O, et al. Antibodies induced by ancestral SARS-CoV-2 strain that cross-neutralize variants from Alpha to Omicron BA.1. Sci Immunol. 2022;7(74):eabo3425. doi:10.1126/sciimmunol.abo3425. PubMed PMID: 35536154; PubMed Central PMCID: PMC9097876.
  • Yan Q, He P, Huang X, et al. Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patients. Emerg Microbes Infect. 2021;10(1):1097–1111. doi:10.1080/22221751.2021.1925594. PubMed PMID: 33944697; PubMed Central PMCID: PMCPMC8183521.
  • Yuan M, Liu H, Wu NC, et al. Structural basis of a shared antibody response to SARS-CoV-2. Science. 2020;369:1119–1123.
  • Zhang Q, Ju B, Ge J, et al. Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2. Nat Commun. 2021;12(1):4210, doi:10.1038/s41467-021-24514-w. PubMed PMID: 34244522; PubMed Central PMCID: PMCPMC8270942.
  • Zhang Y, Yan Q, Luo K, et al. Analysis of B cell receptor repertoires reveals Key signatures of the systemic B cell response after SARS-CoV-2 infection. J Virol. 2022;96(4):1–23.
  • Niu X, Li S, Li P, et al. Longitudinal analysis of T and B cell receptor repertoire transcripts reveal dynamic immune response in COVID-19 patients. Front Immunol. 2020;11:582010, doi:10.3389/fimmu.2020.582010. PubMed PMID: 33117392; PubMed Central PMCID: PMCPMC7561365.
  • Tuekprakhon A, Nutalai R, Dijokaite-Guraliuc A, et al. Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum. Cell. 2022;185(14):2422–2433. doi:10.1016/j.cell.2022.06.005.
  • Kaku CI, Bergeron AJ, Ahlm C, et al. Recall of pre-existing cross-reactive B cell memory following Omicron BA.1 breakthrough infection. Sci Immunol. 2022;7(73):eabq3511. doi:10.1126/sciimmunol.abq3511. PubMed PMID: 35549299; PubMed Central PMCID: PMC9097882.
  • Yu H, Liu B, Zhang Y, et al. SARS-CoV-2 breakthrough infections induce somatically hypermutated broadly neutralizing antibodies against heterologous variants. Research Square; 2022.
  • Wang Z, Zhou P, Muecksch F, et al. Memory B cell responses to Omicron subvariants after SARS-CoV-2 mRNA breakthrough infection in humans. J Exp Med. 2022;219(12). doi:10.1084/jem.20221006. PubMed PMID: 36149398; PubMed Central PMCID: PMCPMC9513381.
  • He P, Liu B, Gao X, et al. SARS-CoV-2 Delta and Omicron variants evade population antibody response by mutations in a single spike epitope. Nat Microbiol. 2022;7(10):1635–1649. doi:10.1038/s41564-022-01235-4. PubMed PMID: 36151403; PubMed Central PMCID: PMCPMC9519457.
  • Zhang L, Cao L, Gao XS, et al. A proof of concept for neutralizing antibody-guided vaccine design against SARS-CoV-2. Natl Sci Rev. 2021;8(8):nwab053, doi:10.1093/nsr/nwab053. PubMed PMID: 34676098; PubMed Central PMCID: PMCPMC8083607.
  • Gaebler C, Wang Z, Lorenzi JCC, et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021. doi:10.1038/s41586-021-03207-w. PubMed PMID: 33461210.
  • Wang Z, Schmidt F, Weisblum Y, et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature. 2021. doi:10.1038/s41586-021-03324-6. PubMed PMID: 33567448.
  • Zhou X, Wang H, Ji Q, et al. Molecular deconvolution of the neutralizing antibodies induced by an inactivated SARS-CoV-2 virus vaccine. Protein Cell. 2021;12(10):818–823. doi:10.1007/s13238-021-00840-z. PubMed PMID: 33909239; PubMed Central PMCID: PMCPMC8080482.
  • Bolotin DA, Poslavsky S, Mitrophanov I, et al. MiXCR: software for comprehensive adaptive immunity profiling. Nat Methods. 2015;12(5):380–381. doi:10.1038/nmeth.3364. PubMed PMID: 25924071.
  • Sun J, Zhu A, Li H, et al. Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient. Emerg Microbes Infect. 2020;9(1):991–993. doi:10.1080/22221751.2020.1760144. PubMed PMID: 32342724; PubMed Central PMCID: PMCPMC7301718.
  • Raybould MIJ, Kovaltsuk A, Marks C, et al. CoV-AbDab: the coronavirus antibody database. Bioinformatics. 2021;37(5):734–735. doi:10.1093/bioinformatics/btaa739. PubMed PMID: 32805021; PubMed Central PMCID: PMCPMC7558925.
  • Wu Y, Wang F, Shen C, et al. A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2. Science. 2020;368:1274–1278.
  • Dejnirattisai W, Zhou D, Supasa P, et al. Antibody evasion by the P.1 strain of SARS-CoV-2. Cell. 2021;184(11):2939–2954. doi:10.1016/j.cell.2021.03.055. PubMed PMID: 33852911; PubMed Central PMCID: PMCPMC8008340.
  • Wang Q, Guo Y, Iketani S, et al. Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5. Nature. 2022. doi:10.1038/s41586-022-05053-w.
  • Henry Dunand CJ, Wilson PC. Restricted, canonical, stereotyped and convergent immunoglobulin responses. Philos Trans R Soc Lond B Biol Sci. 2015;370(1676). doi:10.1098/rstb.2014.0238. PubMed PMID: 26194752; PubMed Central PMCID: PMCPMC4528415.
  • Chen F, Tzarum N, Wilson IA, et al. VH1-69 antiviral broadly neutralizing antibodies: genetics, structures, and relevance to rational vaccine design. Curr Opin Virol. 2019;34:149–159. doi:10.1016/j.coviro.2019.02.004. PubMed PMID: 30884330; PubMed Central PMCID: PMCPMC7266006.
  • Giang E, Dorner M, Prentoe JC, et al. Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus. Proc Natl Acad Sci U S A. 2012;109(16):6205–6210. doi:10.1073/pnas.1114927109. PubMed PMID: 22492964; PubMed Central PMCID: PMCPMC3341081.
  • Bailey JR, Flyak AI, Cohen VJ, et al. Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance. JCI Insight. 2017;2(9). doi:10.1172/jci.insight.92872. PubMed PMID: 28469084; PubMed Central PMCID: PMCPMC5414559.
  • Pappas L, Foglierini M, Piccoli L, et al. Rapid development of broadly influenza neutralizing antibodies through redundant mutations. Nature. 2014;516(7531):418–422. doi:10.1038/nature13764. PubMed PMID: 25296253.
  • Joyce MG, Wheatley AK, Thomas PV, et al. Vaccine-Induced antibodies that neutralize group 1 and group 2 influenza A viruses. Cell. 2016;166(3):609–623. doi:10.1016/j.cell.2016.06.043. PubMed PMID: 27453470; PubMed Central PMCID: PMCPMC4978566.
  • Ramesh A, Darko S, Hua A, et al. Structure and diversity of the rhesus macaque immunoglobulin loci through multiple De Novo genome assemblies. Front Immunol. 2017;8:1407, doi:10.3389/fimmu.2017.01407. PubMed PMID: 29163486; PubMed Central PMCID: PMCPMC5663730.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.